Daniel Anderson

Professor

Department
Department of Chemical Engineering
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Sensors & Monitoring, Synthetic Biology, Biomanufacturing, Tissue Engineering / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture / Therapeutics: Nucleic Acids, Small Molecules, Cell Based Therapy, Vaccines, Proteins & Antibodies, Regenerative Medicine / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Energy & Distribution: Electrochemical Devices / Biomaterials & Bioelectronics: Medical Device Coatings, Health Monitoring, Tissue Repair / Computer Science: Bioinformatics / Diagnostics: Assays

Pioneering smart materials for advancements in medical devices, drug delivery, and gene therapy, with a prolific publication record and significant impact across multiple disciplines.

Background and Experience

Daniel G. Anderson is a leading researcher in the fields of nanotherapeutics and biomaterials and has pioneered the development of smart materials. In addition to the Koch Institute, he holds appointments in MIT’s Department of Chemical Engineering, Institute for Medical Engineering and Science, and Harvard-MIT Division of Health Science and Technology. Anderson received a BA in mathematics and biology from the University of California at Santa Cruz and a PhD in molecular genetics from the University of California at Davis. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 500 papers, patents, and patent applications. He is the recipient of the 2023 Wilhelm Exner Medal.

Awards and Honors

  • Work has resulted in the publication of more than 500 papers, patents, and patent applications
  • Wilhelm Exner Medal | 2023

Technologies

Superbiocompatible Polymers and Hydrogels for Reducing Foreign Body Reactions

Exclusively Licensed Technology / Case number: #18000JQ
Robert Langer / Volkan Yesilyurt / Omid Veiseh / Joshua Doloff / Arturo Vegas / Daniel Anderson
Technology Areas: Biomaterials & Bioelectronics / Chemicals & Materials

A Fully Synthetic Nanoparticle Vaccine Platform Technology Composed of Dendrimer-Based Lipidoid Nanomaterials, Self-Amplifying Ribose Nucleic Acids and Polyethylene Glycol

Exclusively Licensed Technology / Case number: #17873WJH
Robert Langer / David Canner / Jasdave Chahal / Omar Khan / Daniel Anderson / Hidde Ploegh / Tyler Jacks
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living

End-Modified Poly(b-amino ester)s

Non-Exclusively Licensed Technology / Case number: #12049Q
Robert Langer / Gregory Zugates / Andreas Zumbuehl / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
License

Modifications and Coatings to Improve Biocompatibility of Neurological Implants

Exclusively Licensed Technology / Case number: #19323J
Robert Langer / Robert Hevner / Samuel Browd / Brian Hanak / William Shain / Omid Veiseh / Daniel Anderson
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Chemicals & Materials

Hybrid Microcapsules Containing Islets and Anti-Inflammatory Drugs for Diabetes Therapy

Exclusively Licensed Technology / Case number: #14504JQ
Robert Langer / Joshua Cohen / Karolina Siniakowicz / Jennifer Hollister-Lock / Thuy Dang / Gordon Weir / Daniel Anderson
Technology Areas: Biomaterials & Bioelectronics / Therapeutics
Impact Areas: Healthy Living

Novel RNA Modality for Translation in Eukaryotic Cells

Exclusively Licensed Technology / Case number: #19874Q
Daniel Anderson / Robert Wesselhoeft / Piotr Kowalski
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living

Lipomer Nanoparticles for Highly Efficient SiRNA Delivery

Exclusively Licensed Technology / Case number: #14649
Robert Langer / James Dahlman / Avraham Schroeder / Christopher Levins / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living

Modified Alginates for Islet Encapsulation and Diabetes Treatment

Exclusively Licensed Technology / Case number: #14528JQ
Robert Langer / Arturo Vegas / Kaitlin Bratlie / Minglin Ma / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics

Modified Alginates for Use as Anti-Fibrotic Materials

Exclusively Licensed Technology / Case number: #16906JQ
Robert Langer / Omid Veiseh / Joshua Doloff / Arturo Vegas / Minglin Ma / Daniel Anderson
Technology Areas: Biomaterials & Bioelectronics / Chemicals & Materials / Therapeutics

Modified Alginates for Anti-Fibrotic Materials and Applications

Exclusively Licensed Technology / Case number: #21323JQ
Robert Langer / Omid Veiseh / Joshua Doloff / Arturo Vegas / Minglin Ma / Daniel Anderson
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.